Teladoc has seen its definitive breakthrough in 2020 as a result of the pandemic. This major event has furthermore been complemented by the purchase of Livongo Health, creating a huge medtech leader, which is properly positioned for the future. Despite these achievements, shares have recently lost half their value and have not moved up much at all since the start of the pandemic, as all of this improved appeal.